Vijaya Diagnostic CentreQ3 FY24

Vijaya Diagnostic Centre Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,467.4P/E: 74.2Market Cap: ₹15.1K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • The company expects a 14% to 15% growth primarily driven by volume growth (around 15% test volume growth).
  • Non-COVID revenue grew 17% YoY, with 18% volume growth including PH acquisition impact.
  • Volume growth is driven by both existing and new centers across geographies including Hyderabad, Pune, Kolkata, and Tier-2/ Tier-3 cities.
  • Hyderabad remains a key growth market expected to sustain high double-digit growth for the next 2-3 years.
  • The contribution from Hyderabad, currently ~80%, is expected to reduce to approximately 70-75% as other markets like Andhra, Pune, and Eastern India grow.
  • PH Pune acquisition (~Rs.42 crores revenue in FY23) is expected to grow further and contribute to revenue scaling.
  • The company plans to continue adding 12-15 centers annually, with expansion focused on existing and adjacent geographies.
  • Price hikes are limited (~1-1.5% annually); growth is volume-driven rather than price-driven.

See what Vijaya Diagnostic Centre management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no mention of any current or planned fundraising through debt or equity in the transcript.
  • The company funded the PH Diagnostics acquisition (₹147.50 crores) entirely through existing cash reserves.
  • Post-acquisition and dividend payment, the cash reserve stands at ₹158 crores.
  • The strong cash position and healthy balance sheet are highlighted as supporting future expansion.
  • No indications were given about raising additional capital via equity or debt at this time.

See what Vijaya Diagnostic Centre management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company continues to expand into new geographies following a well-thought-out expansion strategy.
  • Recent significant acquisition: PH Diagnostics in Pune for Rs.147.5 crores, fully funded from existing cash reserves.
  • The company is close to reaching 150 centers across 23 cities and 5 states.
  • New hub centers recently launched at Mahbubnagar and Gulbarga as part of Tier-2 city and adjacent geography expansion.
  • Additional two spokes added in Hyderabad network in the recent year.
  • Plans to open 12 to 15 centers annually remain intact, although some may spill over to the next financial year due to delays.
  • Expect increased CAPEX in Pune region with 2-3 hubs expected after acquisition integration.
  • In Kolkata, gradual, organic growth with 1 hub opening every two quarters; East India expansion continues at a measured pace.
  • The company is focusing on integrating PH's operations fully in the next two quarters, including front-end and back-end processes.

Track Vijaya Diagnostic Centre — get its next earnings analysis in your feed

How does Vijaya Diagnostic Centre rank vs peers in Healthcare Services?

Pro feature
ThisVijaya Diagnostic Centre
Rev 3Mar 3

How does Vijaya Diagnostic Centre rank in Healthcare Services?

Compare Vijaya Diagnostic Centre against every Healthcare Services company (Q3 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →